Sterling Capital Management’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
AC
RA
BH
WCM
Sterling Capital Management's ANGO Position: Q2 2026 in Review
Sterling Capital Management reduced its AngioDynamics (ANGO) stake by 41% in Q2 2026, selling an estimated $4.83K and leaving 600 shares worth $7.81K. The position accounts for ﹤0.01% of the portfolio, ranked #2356.
Sterling Capital Management first reported a position in ANGO in Q1 2017 and has held it in 13 quarters since. The position peaked at $651K in Q1 2017. 162 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.
- Sterling Capital Management held 600 shares of AngioDynamics worth $7.81K as of Q2 2026.
- Sterling Capital Management sold 424 AngioDynamics shares in Q2 2026, an estimated $4.83K.
- AngioDynamics made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2356 holding.
- Sterling Capital Management first reported a position in AngioDynamics in Q1 2017 and has held it in 13 quarters since.
- Sterling Capital Management's AngioDynamics position peaked at $651K in Q1 2017.
- 162 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.
Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.